skip navigation
Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection were released on Thursday, November 1, 2012. Please send your comments to ContactUs@aidsinfo.nih.gov by November 15, 2012.
Corrections were made to the guideline. For a description of the changes, please see the correction notice.
(Last updated:11/1/2012; last reviewed:11/1/2012)
Overview CNS Toxicity Dyslipidemia Gastrointestinal Effects Hematologic Effects Hepatic Events Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus Lactic Acidosis Lipodystrophy, Lipohypertrophy, Lipoatrophy Nephrotoxic Effects Osteopenia, Osteoporosis, Osteonecrosis Peripheral Nervous System Toxicity Skin Rash, SJS/EM/TEN, HSR